Statins linked to better survival in blood cancer patients

Statin use may improve survival in patients with some blood cancers

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk of dying from their cancer compared to similar patients who were not taking statins, according to a new study.

Statins linked to better survival in blood cancer patients

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk of dying from their cancer compared to similar patients who were not taking statins, according to a study published today in the journal Blood Advances.

One of UK’s most prescribed drugs could reduce death rate of common blood cancer

Researchers discovered that patients who took a statin had a 61 per cent reduced risk of dying from their cancer

Statin Therapy Linked to Improved Survival in Certain Blood Cancer Patients

In a groundbreaking study published in the prestigious journal Blood Advances, researchers have unveiled a significant association between the use of cholesterol-lowering statin medications and improved survival outcomes among patients diagnosed with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). These findings could potentially reshape the therapeutic landscape for these slow-progressing hematologic malignancies, sugges…

Statins Could Improve Blood Cancer Survival

Research led by the University of Sharjah in the United Arab Emirates shows use of statins, widely prescribed for lowering blood cholesterol, could improve survival in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Both CLL and SLL impact mature B lymphocytes, a type of white blood cell, and are slow growing. The two blood cancers are essentially the same disease, but differ in where they originate, as CLL be…